Proto Labs (NYSE:PRLB – Get Free Report) is expected to post its Q3 2026 results before the market opens on Thursday, October 29th. Analysts expect Proto Labs to post earnings of $0.5960 per share and revenue of $149.04 million for the quarter. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. Investors are encouraged to explore the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, October 29, 2026 at 8:30 AM ET.
Proto Labs (NYSE:PRLB – Get Free Report) last issued its quarterly earnings data on Friday, July 31st. The industrial products company reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.07. The company had revenue of $149.34 million for the quarter, compared to analysts’ expectations of $144.53 million. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. Proto Labs’s revenue for the quarter was up 10.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.41 earnings per share. On average, analysts expect Proto Labs to post $1.46 EPS for the current fiscal year and $1.76 EPS for the next fiscal year.
Proto Labs Stock Up 2.1%
NYSE PRLB opened at $89.54 on Thursday. The company has a market capitalization of $2.14 billion, a price-to-earnings ratio of 71.63 and a beta of 1.38. Proto Labs has a twelve month low of $45.10 and a twelve month high of $99.96. The stock has a fifty day simple moving average of $86.65 and a 200 day simple moving average of $78.33.
Analysts Set New Price Targets
Read Our Latest Analysis on PRLB
Insider Buying and Selling at Proto Labs
In other news, CFO Daniel Schumacher sold 5,000 shares of Proto Labs stock in a transaction on Thursday, September 24th. The shares were sold at an average price of $95.32, for a total value of $476,600.00. Following the completion of the sale, the chief financial officer owned 35,019 shares in the company, valued at $3,338,011.08. The trade was a 12.49% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 10,000 shares of company stock valued at $902,629. Insiders own 1.30% of the company’s stock.
Proto Labs Company Profile
Proto Labs, Inc (NYSE: PRLB), operating as Protolabs, is a digital manufacturing company that provides rapid prototyping and on-demand production services. The company uses automated quoting and manufacturing systems to help engineers and product developers produce custom parts without relying on traditional, lengthy tooling and procurement processes.
Protolabs offers computer numerical control (CNC) machining, injection molding, 3D printing and sheet-metal fabrication. Its services support the development and production of components in a range of materials and are used across industries including automotive, aerospace, medical, electronics and consumer products.
Founded in 1999 by entrepreneur Larry Lukis, the company has expanded its reach beyond its original U.S.
Featured Stories
- Five stocks we like better than Proto Labs
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.
